Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results

Go back to Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results

Rallybio Corp. (RLYB) PT Lowered to $20 at Jones Trading

March 13, 2024 4:11 PM EDT

Jones Trading analyst Catherine Novack lowered the price target on Rallybio Corp. (NASDAQ: RLYB) to $20.00 (from $30.00) while maintaining a Buy rating.

The analyst comments "Rallybio reported 4Q23 earnings ( press release ). Earlier this year, the company announced portfolio prioritization to extend runway... More